Pituitary adenomas result in clinical sequelae and accelerated mortality due to central mass
effects or pituitary hormone hypersecretion and/or insufficiency. The low annual incidence …

Purpose Studies on hyperprolactinemia and hypopituitarism in acromegaly are limited. We
aimed to analyze the preoperative status, postoperative alterations, and correlated factors of …

Purpose High serum prolactin concentrations have been associated with adverse health
outcomes in some but not all studies. This study aimed to examine the morbidity and all …

Non-functioning pituitary adenomas (NFPAs) are benign pituitary tumours that constitute
about one-third of all pituitary adenomas. They typically present with symptoms of mass …

According to current concept, macroprolactin is biologically inactive and, therefore, its
accumulation in serum has little, if any, pathological significance. Authors present the history …

Context Pituitary adenomas are relatively common tumours with diverse clinical features.
Epidemiological data are important to help quantify health burden. Objective To provide in …

Context. An elevated incidence of type 2 diabetes and cardiovascular disease (CVD) has
been reported in patients with nonfunctional pituitary macroadenoma (NFPMA). There is no …

Purpose To compare the clinical, hormonal, and radiological presentation and surgical
outcomes of patients with macroadenomas presenting with pituitary apoplexy and patients …

OBJECTIVE: This study is an updated review of a Southeast Brazilian experience NFPA,
emphasizing clinical features, laboratorial and imaging assessment, therapeutic …

Context Clinically nonfunctioning pituitary adenomas (CNFPAs) typically remain undetected
until mass effect symptoms develop. However, currently, head imaging is performed …